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Background—Although type 2 diabetes mellitus is a risk factor for developing congestive heart failure, the mechanism
leading to heart failure is unclear. We examined the prevalence of left ventricular (LV) systolic and diastolic dysfunction
in patients with type 2 diabetes mellitus in relation to vascular function and myocardial perfusion.
Methods and Results—A prospective observational study of 305 patients with type 2 diabetes mellitus (diabetes duration,
4.55.3 years) referred consecutively to a diabetes clinic were screened for LV systolic and diastolic function by
echocardiography. Vascular function was estimated using noninvasive estimation of pulse pressure, carotid arterial
compliance, total arterial compliance, and valvulo-arterial impedance. The prevalences of LV diastolic dysfunction and
left atrial (LA) volume index 32 mL/m2 were 40% and 32%, respectively. The prevalence of myocardial ischemia on
myocardial perfusion scintigraphy was more frequent in patients with grade 2 diastolic dysfunction and LA volume
index 32 mL/m2 compared with those having normal or grade 1 diastolic dysfunction (P0.002) or LA volume index
32 mL/m2 (P0.001), respectively. Predictors of grade 2 diastolic dysfunction and LA dilation were summed stress
score on myocardial perfusion scintigraphy, total arterial compliance, and valvulo-arterial impedance, whereas pulse
pressure and carotid arterial compliance were not, after adjusting for age, sex, and diabetes duration. On multivariable
modeling, summed stress score (P0.001) and valvulo-arterial impedance (P0.027) remained predictors of grade 2
diastolic dysfunction, and only summed stress score (P0.001) was a predictor of LA dilation.
Conclusions—Abnormal LV filling is closely associated with abnormal myocardial perfusion on myocardial perfusion
scintigraphy, whereas the association of LV filling with vascular function is less prominent.
Clinical Trial Registration—The trial has been registered at www.clinicaltrial.gov with Identifier: NCT00298844.
(Circ Cardiovasc Imaging. 2010;3:24-31.)
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In the past decade, patients with signs and symptoms ofheart failure despite a near normal left ventricular (LV)
systolic function has received growing attention, for which
the term LV diastolic heart failure or heart failure with normal
ejection fraction (HFNEF) has been introduced. It has been
demonstrated that there exists an important association be-
tween HFNEF and type 2 diabetes mellitus (T2DM),1–3 in
which the prevalence of abnormal LV diastolic function has
been reported to be 43% to 75% in these patients.4–6 In
addition, several studies have consistently demonstrated in-
creased mortality rates in patients with HFNEF.7 LV diastolic
function can be evaluated noninvasively by Doppler echocar-
diography, and, in the recent European Consensus Statement on
Diagnosis of HFNEF, Doppler echocardiography has a central
position in establishing the diagnosis.8 Whether HFNEF is
caused by an intrinsic myocardial disorder or related to
vascular disease with abnormal ventriculo-arterial coupling
is, however, still controversial. Better understanding of this is
imperative for implementation of therapeutic interventions to
improve the prognosis of this large patient group.
Clinical Perspective on p 31
To investigate the association between myocardial function
and vascular function in patients with T2DM, we assessed the
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association between vascular disease, arterial compliance, and
myocardial perfusion with the presence of moderate or severe
LV diastolic dysfunction and left atrial (LA) dilation in a T2DM
population with no history of cardiovascular disease.
Methods
Population
In a prospective observational design, 753 patients with T2DM
referred for the first time to the Diabetes Clinic at Odense University
Hospital, Denmark, from January 2006 to December 2007, were
evaluated. Reasons for referral were (1) diabetes education or (2)
glycemic regulation of poorly regulated diabetes. We enrolled
patients ages 20 years with a fasting C-peptide 250 pmol/L. Of
the 753 patients, 431 were eligible and 126 patients declined to
participate; thus, the remaining 305 T2DM patients were enrolled in
the study (Figure 1). The study was carried out according to Good
Clinical Practice, was approved by the Regional Ethics Committee,
and registered at www.clinicaltrials.gov. All participants gave writ-
ten informed consent.
Each patient underwent a single-day program including a cardiovas-
cular risk factor evaluation; a comprehensive Doppler echocardiogram;
myocardial perfusion scintigraphy (MPS); B-mode ultrasound of the
carotid arteries; measurements of brachial, ankle, and toe systolic blood
pressures; and measurement of plasma N-terminal pro–brain natriuretic
peptide (NT-proBNP). Glomerular filtration rate was determined using
a 1-point 51Cr-EDTA clearance procedure.9
Echocardiography
The echocardiograms were obtained on a Vivid 5 GE medical
ultrasound machine with a 2.5-MHz transducer and were stored
digitally for later blinded analysis. For all Doppler recordings, a
horizontal sweep of 100 mm/s was used, and for all Doppler
variables, the average of 5 consecutive beats was measured.
LV Systolic Function
LV ejection fraction (LVEF) and LV volumes were estimated using
the biplane modified Simpson method.8,10 LV systolic dysfunction
was defined as LVEF 50%. Pulsed-wave Doppler was used in the
apical 5-chamber view or apical long-axis view with the cursor
placed in the LV outflow tract. Stroke volume (SV) and cardiac
output (CO) were calculated using the LV outflow tract area and
stroke length from a pulsed-wave Doppler recording of outflow tract
flow. CO was calculated as SV multiplied by heart rate. Based on
continuous-wave Doppler recording of LV outflow, the mean pres-
sure gradient across the aortic valve was measured.
LV dimension were obtained from the parasternal long-axis view.
LV mass index was calculated using the formula (0.8  [1.04  (LVDd
IVSdPWd)3(LVDd)3])0.6 g)/body surface area.10 LV hyper-
trophy was considered moderate to severe if LV mass index was
108 g/m2 (women) and 131 g/m2 (men).10 Relative wall thick-
ness was calculated using the formula (2  PWd)/LVDd.10
LV Diastolic Function
Mitral inflow was assessed with pulsed-wave Doppler obtained with
the transducer in the apical 4-chamber view, with the Doppler beam
aligned perpendicular to the plane of the mitral annulus. The Doppler
sample volume was placed between the tips of the mitral leaflets
during diastole. Color M-mode Doppler echocardiography was done
in the apical 4-chamber view, with the M-mode cursor aligned
parallel with LV inflow. The M-mode cursor was positioned through
the center of inflow, avoiding boundary regions. The propagation
velocity (Vp) was measured as the slope of the first aliasing velocity
from the mitral annulus in early diastole to 4 cm distally into the LV
cavity. Tissue Doppler was used at the septal and lateral mitral
annulus to measure the mitral plane movement. LV filling was
divided into 4 distinct filling patterns, based on a combination of
mitral inflow, tissue Doppler measurements of the mitral plane
movement, and mitral inflow assessed with color M-mode.11 Normal
LV diastolic function was defined as mitral deceleration time: 140 to
240 ms, E/A flow velocity ratio: 0.7 to 1.5, Vp 45 cm/s, and
eseptum 8 cm/s; grade 1 diastolic dysfunction: mitral deceleration
time 240 ms, E/A flow velocity ratio 0.7, Vp 45 cm/s, and
eseptum 8 cm/s; grade 2 diastolic dysfunction: mitral deceleration
time: 140 to 240 ms, E/A flow velocity ratio: 0.7 to 1.5, Vp 45
cm/s, and eseptum 8 cm/s; grade 3 diastolic dysfunction: mitral
deceleration time 140 ms, E/A flow velocity ratio 1.5, Vp 45
cm/s, and eseptum 8 cm/s.
LA Volume Index
LA volume was estimated by the biplane area-length method, using
measurements at the apical 4- and 2-chamber views at end-systole
(maximum LA size).10 LA volume index was calculated as LA
volume divided with the body surface area. LA volume index was
considered moderate or severely increased if it was 32 mL/m2.
The absolute interobserver agreement between 2 observers ob-
tained in 20 randomly selected patients on LV diastolic filling pattern
and LA volume index over or below 32 mL/m2 was 95% (0.91)
and 85% (0.70), respectively.
Myocardial Perfusion Scintigraphy
The MPS examinations were performed in concordance with stan-
dards of the American Society of Nuclear Cardiology using ECG-
gated single-photon emission computed tomography with 99mtech-
netium sestamibi.12 Whenever a potential stress-induced perfusion
defect was observed, an additional rest study was carried out to
evaluate the degree of reversibility. In 269 patients, adenosine stress
(140 g/kg/min) was used, in 26 bicycle exercise stress using the
Bruce protocol, and in 10 dobutamine stress tests. A semiquantitative
visual interpretation was made by 2 observers using a 20-segment
model. A summed stress score (SSS) was calculated. The final result
was decided by consensus. Myocardial ischemia was defined as a
regional perfusion abnormality with a total SSS 4 and at least 1
segment with an SSS 2. Four perfusion patterns were registered:
normal, reversible, mixed, and fixed defects according to the
standards of the American Society of Nuclear Cardiology.12 The 2
observers’ diagnostic accuracy has been reported previously.13
Vascular Function
Total arterial compliance was estimated by calculating the stroke
volume index pulse-pressure ratio (SVi/PP).14 Arterial impedance was
estimated using the valvulo-arterial impedance (Zva) calculated by the
formula (systolic blood pressuremean gradient over the aortic valve)/
stroke volume index.14 Regional vascular compliance was assessed as
carotid arterial compliance (CCAcompliance), using B-mode ultrasound
Figure 1. Enrollment of patients.
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scans of the common carotid arteries and calculated by the formula
(carotid diametermax2carotid diametermin2)/pulse pressure.15
Brachial pulse pressure 50 mm Hg, CCAcompliance 0.25 mm2/
kPa, SVi/PP0.6 mL/m2/mm Hg, and Zva 4 mm Hg/mL/m2 were
considered normal.14
Peripheral Arterial Disease
Carotid intima media thickness (CIMT) was measured semiautomat-
ically as the mean of minimum 200 measurements per location site
(the bulbus region and the proximal end of the common carotid
artery) from digitally stored images using B-mode ultrasound scans
of the posterior wall bilaterally at end-diastole (10-MHz linear
transducer). Each image was also investigated for plaques using the
ARIC study plaque definition.16 The 95% limits of agreement
between 2 observers in 20 randomly selected patients on mean CIMT
was 0.158 to 0.081 mm. The absolute interobserver agreement on
presence of plaques was 98% (0.74). Carotid arterial disease was
defined as mean CIMT1.00 mm and/or the presence of a plaque at
any carotid artery location.
Ankle and toe systolic blood pressure measurements were per-
formed using the strain-gauge technique.17 After 20 minutes, rest
cuffs were placed around the ankles and proximal phalanges of the
big toe. Strain gauges were placed around the distal phalanges of the
big toe. Duplicate measurements of ankle and toe systolic blood
pressures were obtained. Arm systolic and diastolic blood pressures
were measured. The ankle-brachial-index (ABI) and the toe systolic
blood pressure index (TSPI) were calculated as the systolic blood
pressure at each level, respectively, divided by the brachial systolic
blood pressure. Peripheral arterial disease (PAD) was defined as ABI
0.90 and/or TSPI 0.64.18
Statistical Analysis
Continuous variables are presented as mean and standard deviations
and categorical variables as numbers and percentages. We used the
Student t test to test for differences between independent continuous
variables and the 2 test or Fisher exact test to test for differences
between categorical variables. Because of a well-known nongaussian
distribution of NT-proBNP, this parameter was presented as median
and interquartile range, and a Mann–Whitney test was used to
compare groups. We analyzed the association between each outcome
variable (grade 2 diastolic dysfunction and LA volume index 32
mL/m2), and the predefined indicators of vascular function (pulse
pressure, CCAcompliance, SVi/PP-ratio, and Zva), renal function
(GFR), and indicators of LV function (NT-proBNP, LV mass index,
and SSS) using a logistic regression analysis with forced entry of the
confounders: age, male sex, and diabetes duration. Because of
colinearity of the vascular function covariables, these were tested
separately. Each model was analyzed for each separate vascular
function covariable, together with SSS and the above-mentioned
confounders. Results are reported as odds ratios (ORs) with 95% CIs
and corresponding probability values. A probability value0.05 was
considered statistically significant. STATA version 9.2 was used for
calculations.
Results
Characteristics of the 305 patients with T2DM are summa-
rized in Table 1. No patients had a history of cardiovascular
disease. In only 27 patients (9%), LVEF was 50%. LV
diastolic function was abnormal in 121 patients (40%): 67
patients (22%) had grade 1 diastolic dysfunction, 54 patients
(18%) had grade 2 diastolic dysfunction, and no patients had
grade 3 diastolic dysfunction (Table 2). Patients with grade 2
diastolic dysfunction were characterized by higher age (629
versus 5712 years, P0.01), higher NT-proBNP (median,
83; interquartile range, 33 to 789 versus median, 51; inter-
quartile range, 31 to 94 pg/mL; P0.02), higher frequencies
of New York Heart Association (NYHA) class II-IV (37%
versus 18%, P0.001), and lower GFR (8126 versus
9222 mL/min/m2, P0.002). Measures of vascular func-
tion (CCAcompliance, SVi/PP, PP, and Zva) were significantly
correlated, whereas only weak correlation with SSS existed
(Table 2.) Vascular function and LV function are summarized
in Table 3.
Vascular Function, Myocardial Perfusion, and
Grade 2 Diastolic Dysfunction
There were no differences in pulse pressure between patients
with normal or grade 1 diastolic function versus grade 2 diastolic
dysfunction (5913 versus 6112 mm Hg, P0.18). A normal
Table 1. Characteristics
Total (n305) LAVI 32 mL/m2 (n206) LAVI 32 mL/m2 (n99) P
Age, y 58.611.3 56.411.3 63.010.0 0.001
Male sex 166 (54) 109 (53) 57 (58) 0.444
Diabetes duration, y 4.55.3 4.25.1 5.05.6 0.192
BMI, kg/m2 32.25.8 32.25.8 32.25.9 0.985
Systolic blood pressure, mm Hg 138.718.1 136.517.3 143.119.1 0.003
Diastolic blood pressure, mm Hg 79.510.9 78.810.1 80.812.4 0.132
Pulse pressure, mm Hg 59.213.2 57.713.2 62.212.8 0.005
HbA1c, % 7.31.3 7.41.4 7.11.1 0.047
Fasting C-peptide conc, pmol/L 1146644 1109661 1224604 0.145
Fasting insulin conc, pmol/L 106104 9988 120131 0.107
Total cholesterol conc, mmol/L 4.41.0 4.41.1 4.20.9 0.099
Creatinine, mol/L 9024 8718 9633 0.001
NT-proBNP, pg/mL* 61 (31–105) 51 (29–87) 85 (37–266) 0.001
Hypertension 197 (64) 127 (62) 69 (70) 0.170
Current smoker 82 (27) 65 (32) 16 (16) 0.004
Atrial fibrillation† 12 (4) 3 (1) 9 (9) 0.003
Data are presented as meanSD or n (%). BMI indicates body mass index; conc, concentration.
*Median with interquartile range; †tested with Fisher exact test.
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pulse pressure (50 mm Hg) was observed in 82 patients (27%).
In 9 patients (11%) with normal pulse pressure, grade 2 diastolic
dysfunction was found. In contrast, 45 patients (20%) with an
abnormal pulse pressure had grade 2 diastolic dysfunction. In
addition, CCAcompliance (1.070.35 versus 1.240.47 mm2/kPa,
P0.02) and total arterial compliance (SVi/PP) (0.580.14
versus 0.640.19 mL/m2/mm Hg, P0.03) were decreased, and
valvulo-arterial impedance (Zva) increased (4.401.11 versus
4.060.94 mm Hg/mL/m2, P0.02) in patients with grade 2
diastolic dysfunction compared with patients having normal or
grade 1 diastolic dysfunction. This association remained signif-
icant for SVi/PP and Zva after adjustment for age, male sex, and
diabetes duration (Table 4).
Abnormal myocardial perfusion was seen in 92 patients
(30%); most often these perfusion defects were reversible and
suggested single coronary vessel disease (Table 3). In 49
patients, the location of perfusion abnormality suggested
disease in the left anterior descending, in 25 the left circum-
flex, and in 43 the right coronary artery. Abnormal perfusion
was seen in 48% with grade 2 diastolic dysfunction compared
with 26% with normal or grade 1 diastolic dysfunction
(P0.002). Furthermore, SSS remained an independent pre-
dictor of grade 2 diastolic dysfunction when pulse pressure,
CCAcompliance, SVi/PP, or Zva was included in the model
separately, whereas only Zva remained an independent pre-
dictor (Table 5).
Vascular Function, Myocardial Perfusion, and
Moderate or Severe LA Dilation
In 99 patients (32%), LA volume index was moderate or
severely increased (LA volume index 32 mL/m2). Charac-
teristics of patients with LA volume index 32 mL/m2 are
summarized in Tables 1 and 3.
In multivariable logistic regression, the predictors of LA
volume index32 mL/m2 were SVi/PP ratio, Zva, NT-proBNP,
LV mass index, and SSS (Table 3).
SSS remained an independent predictor of moderate or
severe LA dilation when pulse pressure, CCAcompliance, SVi/
PP, or Zva was included in the model separately, whereas
none of these variables remained significant (Table 5).
Vascular Disease
To assess the association with vascular complications, 3 groups
were established. Group I had normal or grade 1 diastolic
dysfunction and LA volume index 32 mL/m2 (n205); group
II, normal or grade 1 diastolic dysfunction and LA volume index
32 mL/m2 (n47); and group III, grade 2 diastolic dysfunction
and LA volume index 32 mL/m2 (n53). T2DM patients in
group 3 had significantly higher prevalence of myocardial
ischemia on MPS and impaired renal function on 1-point
51Cr-EDTA clearance procedure compared with patients in
group 1 (P0.001 and P0.009). In contrast, these patients did
not have a higher prevalence of carotid arterial disease (P0.25)
or PAD (P0.86) (Figure 2).
Discussion
The present study demonstrated in a large population of
patients with T2DM with no history of cardiovascular disease
a low prevalence of LV systolic dysfunction (9%) similar to
the prevalence observed in the general population5; however,
the study confirms a high prevalence of LV diastolic dys-
function (40%) in these patients. Importantly, the study
suggested a close association between the presence of mod-
erate or severe LV diastolic dysfunction and abnormal myo-
cardial perfusion, whereas the association with vascular
function was considerably weaker. Thus, our findings support
that moderate or severe LV diastolic dysfunction in the early
phase of T2DM is closely associated with intrinsic LV
dysfunction. However, such LV diastolic dysfunction is not
closely related to vascular disease with arterial stiffening and
abnormal ventriculo-arterial coupling.
The cardiovascular system can be regarded as a continuous
system of a reservoir, a pump, and vessels. Thus, an abnor-
mality in one component will affect the others. Based on this,
the coupling between the LV and the arteries may play an
important role in the development of heart failure. Increasing
arterial stiffness causes premature return of reflected pulse
waves in late systole leading to increasing systolic blood
pressure and pulse pressure.15 This will cause increased
myocardial oxygen demand, LV hypertrophy, increased wall
stress, and myocardial ischemia, which may cause or aggra-
vate abnormal LV diastolic function and eventually overt
heart failure. This mechanism has been suggested to be
importantly involved in the development of HFNEF, based on
increased pulse pressure, pulse wave velocity, and abnormal
ventriculo-arterial coupling.8,19 Although it is recognized that
T2DM also is associated with increased risk of heart failure,
it is not clear whether this is related to abnormal ventriculo-
arterial coupling or due to a direct effect of hyperglycemia or
hyperinsulinemia on the myocardium, or both. Studies in
patients with diabetes compared with nondiabetic subjects
have demonstrated increased myocardial fibrosis,20,21 and,
importantly, the amount of myocardial fibrosis in diabetes
patients has been suggested further increased in those with an
Table 2. Bivariate Correlation Matrix Among Study Measures
SSS Pulse Pressure CCAcompliance SVi/PP Ratio Zva GFR NT-proBNP
Pulse pressure 0.05
CCAcompliance 0.07 0.47
SVi/PP ratio 0.11 0.63 0.4
Zva 0.11 0.25 0.22 0.79
GFR 0.05 0.19 0.15 0.07 0.05
NT-proBNP 0.17 0.12 0.08 0.05 0.04 0.39
LVMI 0.02 0.16 0.02 0.03 0.01 0.14 0.28
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Table 3. Echocardiography: Cardiovascular and Microvascular Disease
Total
(n305) LAVI 32 mL/m2 (n206) LAVI 32 mL/m2 (n99) P
Echocardiography
LV structure
End-systolic volume, mL 41.515.3 40.112.9 44.419.0 0.025
End-diastolic volume, mL 102.421.1 102.020.2 103.323.0 0.635
LV systolic function
LV ejection fraction, % 60.38.0 61.36.9 58.29.6 0.002
Sseptum, cm/s 7.91.3 8.11.1 7.41.4 0.001
Slateral, cm/s 8.74.6 9.05.4 8.11.9 0.117
Stroke volume index, mL/m2 36.07.6 36.17.7 36.07.4 0.949
Cardiac index, L/min/m2 2.680.60 2.660.58 2.720.65 0.417
LV mass index, g/m2 98.821.0 95.218.5 106.823.6 0.001
Relative wall thickness 0.450.08 0.450.07 0.460.09 0.321
LV hypertrophy, moderate to severe 40 (13) 18 (9) 22 (22) 0.002
LV diastolic function and grade
Peak E-wave velocity, m/s 0.800.16 0.800.16 0.800.17 0.930
Peak A-wave velocity, m/s 0.850.19 0.820.17 0.930.21 0.001
E/A ratio 0.960.25 1.000.23 0.880.26 0.001
DT, ms 22048 21642 22755 0.057
Vp, cm/s 52.016.9 55.615.3 43.116.1 0.001
eseptum, cm/s 8.31.9 8.91.7 7.11.7 0.001
elateral, cm/s 10.51.7 10.72.5 9.52,7 0.001
E/eseptum ratio 10.02.7 9.22.0 11.73.0 0.001
Normal diastolic function 184 (60) 167 (81) 17 (17) 0.001
Grade 1 diastolic dysfunction 67 (22) 38 (18) 29 (29) 0.042
Grade 2 diastolic dysfunction 54 (18) 1 (1) 53 (54) 0.001
Grade 3 diastolic dysfunction 0 0 0
LAVI, mL/m2 28.87.4 25.24.0 37.74.9 0.001
Vascular function
CCAcompliance, mm
2/kPa 1.210.45 1.250.47 1.120.41 0.023
SVi/PP ratio, mL/m2/mm Hg 0.630.18 0.650.19 0.600.16 0.019
Zva, mm Hg/mL/m2 4.120.98 4.050.95 4.241.03 0.116
Myocardial perfusion scintigraphy
Myocardial ischemia 92 (30) 49 (24) 43 (43) 0.001
Perfusion defect size
SSS 4–8 78 (26) 49 (24) 29 (29) 0.349
SSS 9–13* 9 (3) 0 9 (9) 0.001
SSS 13* 5 (2) 0 5 (5) 0.003
Reversibility of perfusion defects
Reversible defects 58 (19) 30 (15) 28 (28) 0.005
Mixed defects* 13 (4) 5 (2) 8 (8) 0.763
Fixed defects* 21 (7) 14 (7) 7 (7) 0.929
No. of involved coronary arteries
1-vessel disease 68 (22) 45 (22) 23 (23) 0.785
2-vessel disease* 23 (8) 4 (2) 19 (19) 0.027
3-vessel disease* 1 (1) 0 1 (1) 0.999
B-mode ultrasound scan of the carotid arteries
CIMTmean, mm 0.820.14 0.810.14 0.850.13 0.009
Carotid arterial disease 129 (42) 76 (37) 53 (54) 0.006
(Continued))
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abnormal MPS.22 In accordance with this, the present study
suggests that advanced diastolic dysfunction, which is often
associated with increased LV stiffness, was related to SSS,
NT-proBNP, LV mass index, total arterial compliance, and
valvulo-arterial impedance. When, myocardial perfusion and
vascular function were assessed, only SSS and valvulo-arte-
rial impedance provided independent information.
In the case of chronic LA volume or pressure overload, the
size of the LA will increase. Thus, in absence of significant
mitral valve disease, intracardiac shunts, or chronic anemia,
LA volume will reflect “chronic” LA pressure overload. The
present study is the first to systematically evaluate LA
volume in a large population of T2DM patients and suggests
that moderate or severe LA dilation is seen in almost one third
of the patients. In the study population, moderate or severe
mitral valve disease was not present, and no patients had
chronic anemia; thus, the most likely cause of LA dilation
was pressure overload. We found a statistically significant
association with LA volume index 32 mL/m2 and SSS,
NT-proBNP, LV mass index, total arterial compliance, and
valvulo-arterial impedance in multivariable analysis. How-
ever, when myocardial perfusion and vascular function were
included in the same model, only SSS was an independent
predictor of LA volume index 32 mL/m2.
These results suggest that the cause of advanced LV
diastolic dysfunction and LA dilation in patients with T2DM
is linked to ischemic myocardium and intrinsic LV dysfunc-
tion and to a lesser degree arterial stiffening with abnormal
ventriculo-arterial coupling. However, as LV diastolic dys-
function was uncommon in the subgroup with normal pulse
pressure, and valvulo-arterial impedance remained predictive
of LV diastolic dysfunction, a component of vascular dys-
function in the development of LV diastolic stiffening cannot
be excluded in this study. Because the majority of perfusion
defects on MPS were reversible and regional, we consider it
likely that the defects were caused by epicardial disease,
although microvascular disease cannot be ruled out. Future
studies should address this issue in detail.
In the present study, we found a prevalence of myocardial
ischemia on MPS of 30%. This is in agreement with previous
studies of T2DM patients without known coronary artery dis-
ease, in which the prevalence has varied from 14% to 32%.23–25
Study Limitations
Despite great effort, almost one third of eligible patients
refused to participate in the study. Although no statistical
differences were present between the study group and the
nonparticipants with regard to age and diabetes duration (data
not shown), selection bias cannot be ruled out.
When planning and conducing the present study, no
ASE/EAE consensus existed on grading LV diastolic dys-
function. This was, however, introduced by ASE/EAE in
February 2009.26 Although the grading of LV diastolic
function in the present study and the new recommendations
are very alike there are minor differences in the cut off of E/A
ratio and mitral deceleration time. Specifically, our definition
of grade 1 diastolic dysfunction is more restrictive than the
Table 3. Continued
Total
(n305) LAVI 32 mL/m2 (n206) LAVI 32 mL/m2 (n99) P
Ankle and toe systolic blood pressure
Ankle systolic blood pressure, mm Hg 162.526.1 162.022.5 163.632.3 0.613
Toe systolic blood pressure, mm Hg 125.729.5 125.726.8 125.734.6 0.995
PAD 45 (15) 25 (12) 20 (20) 0.063
1-Point 51Cr-EDTA clearance procedure
GFR, mL/min/m2 89.623.0 92.422.3 83.623.3 0.001
Impaired renal function 29 (10) 17 (8) 12 (12) 0.281
Data are presented as meanSD or n (%).
*Tested with Fisher exact test.
Table 4. Predictors of Grade 2 Diastolic Dysfunction and
LAVI >32 mL/m2
Grade 2 Diastolic Dysfunction
Adjusted OR per SD
(95% CI) P
Covariables
Pulse pressure 1.10 (0.81–1.50) 0.528
CCAcompliance 0.72 (0.51–1.01) 0.060
SVi/PP ratio 0.69 (0.48–0.98) 0.039
Zva 1.49 (1.11–2.02) 0.009
GFR 0.67 (0.47–0.95) 0.027
NT-proBNP 1.61 (1.16–2.24) 0.005
LVMI 1.37 (1.01–1.86) 0.046
SSS 2.31 (1.57–3.39) 0.001
LAVI 32 mL/m2
Adjusted OR per SD
(95% CI) P
Covariables
Pulse pressure 1.21 (0.94–1.57) 0.142
CCAcompliance 0.86 (0.65–1.13) 0.266
SVi/PP ratio 0.74 (0.56–0.99) 0.040
Zva 1.35 (1.04–1.75) 0.023
GFR 0.88 (0.65–1.18) 0.388
NT-proBNP 2.06 (1.32–3.21) 0.001
LVMI 1.65 (1.26–2.17) 0.001
SSS 2.80 (1.89–4.14) 0.001
Separate regression models were run for all participants for grade 2 diastolic
dysfunction and LAVI 32 mL/m2. All listed covariables were tested separately
after forced entry of age, male sex, and diabetes duration in the regression models.
Outcome variables are grade 2 diastolic dysfunction and LAVI 32 mL/m2.
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published guideline. This was chosen because many patients
were middle-aged or elderly, and it is well known that even
among healthy subjects ages 60 years, E/A ratios 1.0 and
mitral deceleration times 200 ms are frequently seen and
considered normal.26 However, we did perform a post hoc
reanalysis of our data based on the new definition (data not
presented), which led to the same overall conclusions as
presented.
Although there was clear overweight of patients with short-
ness of breath on exertion (NYHA class II), it must be
emphasized that the population identified in this study with
diastolic dysfunction did not strictly represent patients with
HFNEF.
We chose a cutoff point of CIMT 1.00 mm. We recog-
nize that this in a young person may be abnormal and in an
elderly subject normal. However, most patients in our study
were ages 50 to 70 years, where a cutoff of 1.00 mm seems
reasonable.27 In addition, this cutoff aids comparison with the
large epidemiological study in which this cutoff point has
been used.27
The gold standard for assessment of ventricular and arterial
elastance is invasive assessment of end-diastolic pressure and
cardiac output. Because the number of participants was large
(n305) and the patients did not have a clinical indication for
an invasive study, we did not consider it justified or ethical to
perform invasive assessment of effective arterial elastance. In
addition, all chosen noninvasive estimates have been vali-
dated invasively.
Conclusion
The prevalence of LV diastolic dysfunction was high in
patients with T2DM with no history of cardiovascular dis-
ease. The study suggested a close association between the
presence of advanced LV diastolic dysfunction and abnormal
myocardial perfusion on MPS. In contrast, the association
with abnormal vascular function was considerably less prom-
inent. Thus, our findings support that moderate or severe LV
diastolic dysfunction and LA dilation in the early phase of
T2DM is closely associated with intrinsic LV dysfunction.
However, such LV diastolic dysfunction and LA dilation are
not closely related to vascular disease with arterial stiffening
and abnormal ventriculo-arterial coupling.
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CLINICAL PERSPECTIVE
In the past decade, the term left ventricular (LV) diastolic heart failure or heart failure with normal ejection fraction has
been introduced. The symptoms of heart failure are believed to be caused by abnormalities in LV filling, which are
frequently seen in patients with type 2 diabetes mellitus. Whether LV diastolic dysfunction in patients with type 2 diabetes
mellitus is caused by an intrinsic myocardial disorder or related to vascular disease is, however, still controversial. Better
understanding of this is imperative for implementation of therapeutic interventions to improve the prognosis of these
patients. In the present study, patients with type 2 diabetes mellitus with no history of heart failure or coronary artery
disease referred to a diabetes clinic for the first time (n305) were studied. The present study demonstrated a low
prevalence of LV systolic dysfunction (9%); however, the study confirmed a high prevalence of LV diastolic dysfunction
(40%). Importantly, the study suggested a close association between the presence of moderate or severe LV diastolic
dysfunction and abnormal myocardial perfusion on myocardial perfusion scintigraphy, whereas the association with
vascular function was considerably less prominent. Thus, our findings support the hypothesis that moderate or severe LV
diastolic dysfunction and left atrial dilation in the early phase of type 2 diabetes mellitus are closely associated with
intrinsic LV ischemic dysfunction. However, such LV diastolic dysfunction and left atrial dilation are not closely related
to vascular disease with arterial stiffening and abnormal ventriculo-arterial coupling.
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